title: Cisapride and intestinal dysmotility: the final word?
authors.affiliation: Regional Neonatal Unit, Royal Maternity Hospital, Belfast, UK. stan.craig@royalhospitals.n-i.nhs.uk
authors.forename: J S
authors.initials: JS
authors.lastname: Craig
mesh_terms: D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D020117:Cisapride / Q000009:adverse effects* / Q000627:therapeutic use; D004066:Digestive System Diseases / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005769:Gastrointestinal Motility; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D005765:Gastrointestinal Agents; D020117:Cisapride